EDIT short interest
Editas Medicine Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 37,109,260 |
|---|---|
| Change vs prior report | 7,145,067 (+23.9%) |
| Change over six months | +210.8% |
| Days to cover | 9.35 (sector: 3.78) |
| Average daily volume | 3,970,413 |
| Rank in Healthcare | #132 of 922 by days to cover |
EDIT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 37,109,260 | +23.9% | 9.35 | 3,970,413 |
| 2026-09-15 | 29,964,193 | -0.9% | 15.72 | 1,906,017 |
| 2026-08-31 | 30,232,239 | +22.5% | 8.96 | 3,372,729 |
| 2026-08-14 | 24,686,466 | +5.2% | 14.59 | 1,692,123 |
| 2026-07-31 | 23,464,219 | +5.7% | 18.19 | 1,289,898 |
| 2026-07-15 | 22,197,638 | -1.2% | 8.02 | 2,766,681 |
| 2026-06-30 | 22,473,029 | +22.0% | 7.21 | 3,116,110 |
| 2026-06-15 | 18,414,894 | +22.2% | 7.70 | 2,390,764 |
| 2026-05-29 | 15,066,130 | +57.6% | 3.36 | 4,478,910 |
| 2026-05-15 | 9,561,026 | -4.5% | 8.56 | 1,116,594 |
| 2026-04-30 | 10,007,345 | -8.3% | 7.07 | 1,415,098 |
| 2026-04-15 | 10,915,607 | -8.6% | 6.48 | 1,684,449 |
| 2026-03-31 | 11,941,373 | +3.6% | 8.62 | 1,384,934 |
| 2026-03-13 | 11,522,947 | -3.1% | 5.07 | 2,272,804 |
| 2026-02-27 | 11,890,283 | +1.2% | 8.20 | 1,449,253 |
| 2026-02-13 | 11,747,144 | +2.5% | 7.99 | 1,469,564 |
| 2026-01-30 | 11,464,526 | -3.1% | 6.11 | 1,875,153 |
| 2026-01-15 | 11,829,004 | +4.5% | 6.04 | 1,959,829 |
| 2025-12-31 | 11,320,572 | +1.5% | 6.50 | 1,741,224 |
| 2025-12-15 | 11,154,083 | +5.5% | 6.36 | 1,753,452 |
| 2025-11-28 | 10,568,381 | +5.6% | 7.88 | 1,341,342 |
| 2025-11-14 | 10,005,943 | +15.5% | 4.99 | 2,006,151 |
| 2025-10-31 | 8,665,653 | +13.7% | 2.97 | 2,919,107 |
| 2025-10-15 | 7,619,416 | +2.2% | 2.17 | 3,508,259 |
| 2025-09-30 | 7,456,270 | -1.4% | 2.36 | 3,165,097 |
import finzdata as yf
yf.Ticker("EDIT").short_interest # every report since 2017
yf.Client().short_interest(["EDIT"], start="2018-01-01")Healthcare short interest · EDIT price history · Who owns EDIT · All short interest